Mrna Therapeutics

Pic:getty/remotevtx

Pfizer sets out strategy to win in mRNA

By Rachel Arthur

Having built up its mRNA expertise with its COVID-19 vaccine, Pfizer now sets out its strategy for the future. “Going forward, we plan to continue to capitalize on the leadership we have built in both mRNA R&D and manufacturing."